Tove Skjelbakken
Tove Skjelbakken
:
Borte bra, men hjemme best
Trygve S. Ellingsen,
Jostein Lappegård,
Tove Skjelbakken,
Ellisiv B. Mathiesen,
Inger Njølstad,
Sigrid Kufaas Brækkan
et al.:
The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
Research and Practice in Thrombosis and Haemostasis (RPTH) 2018 DOI
Laila Arnesdatter Hopstock,
Elisabeth Bøe Utne,
Alexander Horsch,
Tove Skjelbakken
:
The association between anemia and falls in community-living women and men aged 65 years and older from the fifth Tromsø Study 2001-02: a replication study
Jostein Lappegård,
Trygve Ellingsen,
Tove Skjelbakken,
Ellisiv B. Mathiesen,
Inger Njølstad,
Tom Wilsgaard
et al.:
Red cell distribution width is associated with future risk of incident stroke: The Tromsø Study
Dag Torfoss,
Tone Fladhagen,
Harald Holte,
Lorentz Brinch,
Fredrik Hellem Schjesvold,
Yngvar Fløisand
et al.:
Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
Clinical Microbiology and Infection (CMI) 2016 DOI
Trygve Ellingsen,
Jostein Lappegård,
Tove Skjelbakken,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
Impact of red cell distribution width on future risk of cancer and all-cause
mortality among cancer patients – the Tromsø Study
Trygve Ellingsen,
Jostein Lappegård,
Tove Skjelbakken,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population
Jostein Lappegård,
Trygve Ellingsen,
Anders Vik,
Tove Skjelbakken,
Jan Brox,
Ellisiv B. Mathiesen
et al.:
Red cell distribution width and carotid atherosclerosis progression: The tromsø study
Tove Skjelbakken,
Jostein Lappegård,
Trygve Ellingsen,
Elizabeth Barrett-Connor,
Jan Brox,
Maja-Lisa Løchen
et al.:
Red cell distribution width is associated with incident myocardial infarction in a general population: The tromsø study
Audhild Nyrnes,
Inger Njølstad,
Ellisiv B. Mathiesen,
Tom Wilsgaard,
John-Bjarne Hansen,
Tove Skjelbakken
et al.:
Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø Study
Gender Medicine 2012 DOI
Tove Skjelbakken,
inger marie Dahl,
Maja-Lisa Løchen
:
Changes in Body Mass Index and Smoking Habits Have a Different Impact on Hemoglobin Concentration in Men and Women: A Longitudinal Follow-Up of the Tromso Study, 1994-2002
Gender Medicine 2010 DOI
Jon-Magnus Tangen,
Yngvar Fløisand,
Einar Haukås,
Inger Anne Næss,
Tove Skjelbakken,
Camilla I Stapnes
et al.:
Overlevelse hos voksne med akutt lymfoblastisk leukemi :
Tidsskrift for Den norske legeforening 2010 DOI
Lone Jørgensen,
Tove Skjelbakken,
Maja-Lisa Løchen,
Luai Ahmed,
Åshild Bjørnerem,
Ragnar M Joakimsen
et al.:
Anemia and the risk of non-vertebral fractures: the Tromso Study
Osteoporosis International 2010 DOI
H. Johnsen,
Anne Husebekk,
Tove Skjelbakken
:
Severe antibody-mediated agranulocytosis
International Journal of Laboratory Hematology (IJLH) 2008 DOI
Tove Skjelbakken,
inger marie Dahl,
Tom Wilsgaard,
Bodil Langbakk,
Maja-Lisa Løchen
:
Changes in haemoglobin levels according to changes in body mass index and smoking habits, a 20-year follow-up of a male cohort - The Tromso Study 1974-1995
European Journal of Epidemiology (EJE) 2006 DOI
Tove Skjelbakken,
Tom Wilsgaard,
Olav Helge Førde,
Egil Arnesen,
Maja-Lisa Løchen
:
Haemoglobin predicts total mortality in a general young and middle-aged male population. The Tromso Study
Scandinavian Journal of Clinical and Laboratory Investigation 2006
Tove Skjelbakken,
B Langbakk,
Inger Marie Dahl,
Maja-Lisa Løchen
:
Haemoglobin and anaemia in a gender perspective: The Tromso Study
European Journal of Haematology 2005
Tove Skjelbakken,
Kirsti Rakkenes,
Lars Mandelkow,
Marla Clayman,
Mirjam Lauritzen,
Anne Regine Lager
:
Stairway to SDM: Building a matrix to ensure the integration of shared decision making in a hospital
2023
Tove Skjelbakken,
Anne Regine Lager,
Elisabeth Sundkvist,
Kirsti Rakkenes,
Lars Mandelkow,
Margrethe Aase Schaufel
et al.:
Leserbrief zu “New status report from Norway: Implementation of patient involvement in Norwegian health care” (ZEFQ) 171 (2022) 105–112 von J. Kasper et al.
Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 04. Nov 2022 DOI
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Leif Arvid Øvernes,
Mirjam Lauritzen,
Tove Skjelbakken
:
Nytteverdien av behandling for voksne med primær psykose: dokumentasjonsgrunnlag for samvalgsverktøy
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Kirsti Rakkenes,
Tove Skjelbakken
:
Nytteverdien av behandling for muskelknuter i livmor: dokumentasjonsgrunnlag for samvalgsverktøy
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Tove Skjelbakken
:
Gir tillegg av cellegift bedre effekt enn hormonbehandling alene mot prostatakreft med spredning? Cochrane - Kort oppsummert
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Anna Klara Måseide,
Tove Skjelbakken
:
Nytteverdien av behandling for prostatakreft uten spredning: dokumentasjonsgrunnlag for samvalgsverktøy
Therese Kristine Dalsbø,
Kristin Thuve Dahm,
Tove Skjelbakken
:
Tidlig hormonbehandling mot prostatakreft med spredning gir trolig bedre resultat. Cochrane - kort oppsummert
Lone Jørgensen,
Tove Skjelbakken,
Maja-Lisa Løchen,
Luai A. Ahmed,
Åshild Bjørnerem,
Ragnar M Joakimsen
et al.:
Anemia and the risk of non-vertebral fractures
Bone 2010 DOI
Tove Skjelbakken
:
Haemoglobin, anaemia and haematological malignancies
2006
The 50 latest publications is shown on this page. See all publications in Cristin here →